期刊文献+

MiR-122调控肝癌遗传印记基因PEG10的实验研究 被引量:5

MIR-122 regulates the expression of PEG10 in hepatoma cell lines
原文传递
导出
摘要 目的探讨遗传印记基因PEG10功能的异常与miRNA失调控的相关性。方法通过生物信息学网站TargetScan预测可能参与PEG10调控的miRNA分子,筛选到miR~122。通过基于taqman探针的实时定量逆转录聚合酶链反应,比较miR-122在原代正常肝细胞和3株肝癌细胞株(Huh7,Hep3B,HepG2)中的表达差异。将miR-122的分子前体转染HepG2细胞,观察转染前后PEG10在mRNA和蛋白水平的表达变化。多组均数间比较采用秩和检验,配对样本组间差异比较采用t检验。结果生物信息学预测结果显示,miR-122可能参与了PEG10的调控。实时定量逆转录聚合酶链反应结果显示,PHHC,Huh7、HepG2、Hep3B细胞miR-122的表达量(2^△ △ Ct值)分别为1.0578±0.0975、0.5600±0.0632、0.0068±0.0012、0.0058±0.0008,H=9.667,P〈0.05。与原代正常肝细胞相比,miR-122在肝癌细胞株中表现为完全(Hep3B、HepG2细胞)或部分缺失(Huh7细胞),其表达水平与PEG10呈负相关。将miR-122分子前体转入HepG2细胞后,PEG10在mRNA水平并未显示出明显的下调,但Western blot结果提示miR-122分子前体明显抑制了PEG10蛋白的表达。结论miR-122参与了遗传印记基因PEG10的调控,其调控主要发生在翻译阶段,即蛋白质水平。miRNA的失调控与肝癌的发生密切相关,其功能的异常可能早于受其调控的癌基因或抑癌基因的改变,是肝癌发生的早期事件,这为肝癌的早期预警和基因治疗提供了新思路。 Objective Our previous work indicated that oeverexpresssion of imprinting gene PEG 10 is associated with malignant phenotype of hepatocellular carcinoma. The aim of this study is to explore whether disregulation of PEG10 leads to dysregulation of microRNAs. Methods In silico analysis using TargetScan indicated that miR-122 could regulate the expression of PEG10. The expression of miR-122 in three hepatoma cell lines, Huh7, Hep3B and HepG2 and in primary human normal liver cell were compared using real time RT-PCR. After pre-miR-122 was transfected into HepG2 cell, the levels of PEG 10 mRNA and protein were measured. Results In silico analysis revealed that miR-122 could regulate the expression of PEG 10. Real time RT-PCR indicated that miR-122 was not expressed in Hep3B and HepG2 cells, and only weakly expressed in Huh7 cells, but highly expressed in primary human normal liver ceils. The expression of miR-122 was negatively correlated with the expression of PEG10. After pre-miR122 was transfected into HepG2, the mRNA level of PEG10 was not increased, whereas the protein level of PEG 10 was increased. Conclusion miR-122 may be involved in regulation of PEG10 expression.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2010年第4期288-291,共4页 Chinese Journal of Hepatology
基金 国家自然科学基金(30471983,30872237) 国家重点基础研究发展计划(973计划,2007CB512900)
关键词 肝细胞 基因疗法 MIRNA 遗传印记基因PEG10 Carcinoma, hepatocellular Gene therapy miRNA Genetic imprinting gene PEG10
  • 相关文献

参考文献15

  • 1Braconi C,Patel T.MicroRNA expression profiling:a molecular tool for defining the phenotype of hepatocellular tumors.Hepatology,2008,47:1807-1809.
  • 2Vamholt H,Drebber U,Schulze E et al.MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.Hepatology,2008,47:1223-1232.
  • 3Ladeiro Y,Couchy G,Balabaud C,et al.MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.Hepatology,2008,47:1955-1963.
  • 4Gramantieri L,Ferracin M,Fornari F,et al.Cyclin G1 is a target of miR-122a,a microRNA frequently down-rregulated in human hepatocellular carcinoma.Cancer Res,2007,67:6092-6099.
  • 5Meng F,Henson R,Wehbe-Janek H,et al.MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.Gastroenterology,2007,133:647-658.
  • 6Wang Y,Lee AT,Ma JZ,et al.Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.J Biol Chem,2008,283:13205-13215.
  • 7常莹,陶璐薇,陈孝平,周秀敏,宋宇虎,黄锦,张琼,林菊生.肝癌组织中遗传印记基因PEG10表达的特异性及其意义[J].世界华人消化杂志,2005,13(12):1408-1411. 被引量:27
  • 8黄锦,林菊生,常莹,周秀敏.靶向遗传印记基因PEG10的siRNA真核表达载体的构建及鉴定[J].肿瘤防治研究,2007,34(2):86-88. 被引量:5
  • 9黄锦,林菊生,董旭旸,常莹,宋宇虎.PEG10基因siRNA真核表达载体的构建及其对肝癌HepG2细胞凋亡的影响[J].第四军医大学学报,2007,28(3):206-209. 被引量:7
  • 10Wiley CD,Matundan HH,Duselis AR,et al.Patterns of hybrid loss of imprinting reveal tissue-and cluster-specific regulation.PLoS One,2008,3:e3572.

二级参考文献47

  • 1HubertE.Blum.Molecular therapy and prevention of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2003,2(1):11-22. 被引量:5
  • 2常莹,陶璐薇,陈孝平,周秀敏,宋宇虎,黄锦,张琼,林菊生.肝癌组织中遗传印记基因PEG10表达的特异性及其意义[J].世界华人消化杂志,2005,13(12):1408-1411. 被引量:27
  • 3Vondran FW, Katenz E, Schwartlander R, et al. Isolation of primary human hepatocytes after partial hepatectomy: criteria for identification of the most promising liver specimen. Artif Organs, 2008, 32: 205-213.
  • 4Kim KS, Kang KW, Seu YB, et al. Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech Ageing Dev, 2009, 130:179-188.
  • 5Shamanin VA, Sekaric P, Androphy EJ. hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p 14ARF- p53 pathway and efficient immortalization of human mammary epithelial cells. J Virol, 2008, 82: 3912-3920.
  • 6Baumgartner BL, Lundblad V. Telomere identity crisis. Genes Dev, 2005, 19: 2522-2525.
  • 7Zhao Q, Yang Y, Yu J, et al. Posttranscriptional regulation of the telomerase hTERT by gambogic acid in human gastric carcinoma 823 cells. Cancer Lett, 2008, 262:223-231.
  • 8Fujii S, Maeda H, Wada N, et al. Establishing and characterizing human periodontal ligament fibroblasts immortalized by SV40T- antigen and hTERT gene transfer. Cell Tissue Res, 2006, 324:117- 125.
  • 9Kobayashi N, Miyazaki M, Fukaya K, et al. Treatment of surgically induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes. Cell Transplant, 2000, 9: 733- 735.
  • 10Kawashita Y, Guha C, Moitra R, et al. Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat. J Hepatol, 2008, 49: 99-106.

共引文献31

同被引文献92

  • 1黄锦,林菊生,董旭旸,常莹,宋宇虎.PEG10基因siRNA真核表达载体的构建及其对肝癌HepG2细胞凋亡的影响[J].第四军医大学学报,2007,28(3):206-209. 被引量:7
  • 2董志珍,姚登福,邹黎,姚敏,邱历伟,吴信华,吴玮.转化生长因子β1诊断肝癌和肝癌监测转移的临床价值[J].中华肝脏病杂志,2007,15(7):503-508. 被引量:13
  • 3Bota J, Chivalric RR, O'Donnell KA, et al. Therapeutic miRNA delivery suppresses tumorigenesis in a murine liver cancer model [J] Cell, 2009, 137(6): 1005 -1017.
  • 4Cornflour C, Factor VM, Andersen JB, et al. Loss of miRNA- 122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties [ J]. Onco- gene ,2009,28 (40) :3526 - 3536.
  • 5Foment F, Grampian L, Giannini C, et al. miRNA-122/eyclin G1 interaction modulates p53 activity and affects doxorubiein sen- sitivity of human adenocarcinomata cells[J]. Cancer Res, 2009, 69(14) : 5761 -5767.
  • 6Furuta M, Ozawkie KI, Kanaka S, et al. miRNA-124 and miR- NA-203 are epigenetically silenced tumor-suppressive Microfloras in hepatocellular carcinoma [ J ]. Carcinogenesis, 2010,31 (5) : 766 - 776.
  • 7Ivanovo I, Ball AS, Diag RL, et al. Microfloras in the miRNA- 106b family regulate p21/CDKN1A and promote cell cycle pro- gression [ J ]. Mol Cell Bio1,2010,28 ( 7 ) : 2167 - 2174.
  • 8Foment F, Lazzo M, Chico P, et al. miRNA-199a-3p regulates m Tot and c-Met to influence the doxorubicin sensitivity of human adenocarcinomata cells[ J]. Cancer Res,2010, 70(12) : 5184 - 5193.
  • 9An FF, Wang H, Chen YC, et al. Ahs-let-7g inhibits prolifera- tion of hepatocellular carcinoma Cells by down-regulation of c-Myc and up-regulation of p16(INK4A) [ J]. Int J Cancer, 2010,128 : 319 -331.
  • 10Li AM, Poon RT, Auk JM. miRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties [ J ]. Biochem Biophys Res Commun, 2010,394 (3) : 623 - 627.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部